← Eichor
Condition: Esophageal Cancer Stage Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Esophageal Cancer Stage

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of Tislelizumab Combined With Chemoradiotherapy and Surgery for Unresectable Esophageal Squamous Cell Carcinoma
Phase 2 · 8 location(s) · Ming-Yu Lien · NCT07039162Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC.
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT06452602A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (
Phase 3 · 88 location(s) · Daiichi Sankyo · NCT06644781A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)
Phase 1 · 37 location(s) · Aurigene Discovery Technologies Limited · NCT05865002Folfox+Irinotecan+Chemort In Esophageal Cancer
Phase 2 · 3 location(s) · Massachusetts General Hospital · NCT04656041CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC
Phase 3 · 1 location(s) · Fudan University · NCT06964568Efficacy and Safety of Adebrelimab Combined With Chemoradiotherapy in Patients With Unresectable Locally Advanced or Pos
Phase 2 · 1 location(s) · Nanfang Hospital, Southern Medical University · NCT06885814Adebrelimab Combined With Neoadjuvant Chemotherapy in Borderline Resectable Locally Advanced Esophageal Squamous Cell Ca
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT07638436A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
Phase 1 · 2 location(s) · Immunome, Inc. · NCT07578571A Study of Perioperative Camrelizumab Combined With Chemotherapy in Patients With Resectable ESCC
Phase 2 · 1 location(s) · The First Affiliated Hospital of Zhengzhou University · NCT05182944Molecular Assessment for Gastro-Esophageal Cancer
NA · 1 location(s) · KU Leuven · NCT06346054A Study of SH009 Injection in Patients With Advanced Solid Tumors.
Phase 1 · 1 location(s) · Nanjing Sanhome Pharmaceutical, Co., Ltd. · NCT07390838Neoadjuvant ChemoRadiotherapy Followed by Immunotherapy and Surgery for Resectable Esophageal Squamous Cell Carcinoma（CR
Phase 2 · 1 location(s) · Zhejiang Cancer Hospital · NCT06509568Ivonescimab Plus Short-Course Hypofractionated Radiotherapy as Second-Line Therapy for Esophageal Squamous Cell Carcinom
Phase 2 · 1 location(s) · Anhui Provincial Hospital · NCT07188103A Clinical Study of KK2260 in Patients With Advanced or Metastatic Solid Tumors
Phase 1 · 14 location(s) · Kyowa Kirin Co., Ltd. · NCT06248411MRD-Guided Consolidation Therapy Following Definitive Radiotherapy in Esophageal Cancer
Phase 2 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06498752A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors
Phase 1 · 7 location(s) · Shanghai Henlius Biotech · NCT07518043Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Phase 1 · 39 location(s) · SystImmune Inc. · NCT05983432Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenoca
Phase 2 · 2 location(s) · Jiangsu HengRui Medicine Co., Ltd. · NCT07102901PD-1 Inhibitors Combined With Local Therapy at Different Timings in Oligometastatic ESCC
Phase N/A · 1 location(s) · Fudan University · NCT07697859A Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F)
Phase 1/Phase 2 · 22 location(s) · Merck Sharp & Dohme LLC · NCT07405151Surufatinib in Combination With Neoadjuvant Chemo-immunotherapy and Concurrent Chemoradiotherapy for Patients With Unres
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT07086469A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer
Phase 2 · 10 location(s) · Memorial Sloan Kettering Cancer Center · NCT06123338Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors
Phase 1 · 1 location(s) · Baylor College of Medicine · NCT03740256Neoantigen Vaccines in Esophageal Squamous Cell Carcinoma
Phase 2 · 1 location(s) · Sichuan University · NCT06675201Combination Immunotherapy of Adebrelimab With Apatinib and Tegafur, Gimeracil and Oteracil Potassium Capsules for Immune
Phase 2 · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT06339619A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Parti
Phase 2 · 54 location(s) · Bayer · NCT06760819A Phase II Clinical Study to Evaluate HLX43 in Patients With Recurrent/Metastatic ESCC Failed or Intolerance to Standard
Phase 2 · 1 location(s) · Shanghai Henlius Biotech · NCT06769113Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer
Phase 2 · 3 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06421376DBC-664 in Adult Patients With Solid Tumors
Phase 1 · 3 location(s) · Duboce Biopharmaceuticals, Inc. · NCT07705035
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.